Exogenous FGF4 decreases osteogenic differentiation of mESCs. by Sung-Ho Kook (445098)

Subjects:

GSK343 decreased tumor stemness. by Laura V. Bownes (10276762)

“…Treatment with GSK343 significantly decreased tumorsphere formation by both the COA3 (A) and COA6 (B) cells, representing a decrease in stem cell-like phenotype. …”

Naloxone decreases the number of apoptotic cells induced by morphine but does not affect their profile. by Dafna Willner (605895)

Subjects:

The PRAME-AS knockout cells showed a decrease in migration, proliferation, stemness, and viability. by Zahra Hosseininia (22265113)

A decrease in CD44+ cells in response to hypoxia. by Daniel V. Brown (3797809)

CD47 expression is decreased in hematopoietic progenitor cells in patients with myelofibrosis by A. Nonino (6072632)

“…We compared CD47 expression in hematopoietic stem and progenitor cells of patients with MF and controls and found it to be decreased in progenitors of MF. …”

MSCs decrease lung inflammation. by Konrad Urbanek (439073)

<i>Vps13</i> mutant flies show a decreased life span, age dependent impairment of locomotor function and neurodegeneration. by Jan J. Vonk (3686662)

Ketamine decreases NSC viability in a dose-dependent manner. by Shiva Mansouri (2838086)

Therapeutic administration of hMSCs failed to decrease pulmonary inflammation or modify BAL inflammatory cell counts in experimental severe influenza. by Ilyse Darwish (446378)

Therapeutic administration of mMSCs failed to decrease pulmonary inflammation or modify BAL inflammatory cell counts in experimental severe influenza. by Ilyse Darwish (446378)

HDM exposure results in increased MIP-2 and decreased IFNα and IL-13. by Jennifer A. Phan (535730)

“…HDM exposure increased bronchoalveolar lavage MIP-2 (A), and decreased IFNα (B) and IL13 (C). There was no effect of HDM exposure on BAL protein (D), nor were there any effects of HRV-1B infection alone, or combined effects of HDM exposure and HRV-1B infection on any of these parameters. * indicates a significant difference between groups. …”

hMSC adjunctive therapy failed to decrease pulmonary inflammation or prevent ALI compared to antiviral therapy alone in experimental severe influenza. by Ilyse Darwish (446378)

“…<p>Eight-week old male C57Bl/6 mice infected with 425 EID₅₀ influenza A/PR/8 virus were administered 2.5 mg/kg oseltamivir in 100 ul ddH2O via gavage, 1×daily for 5 days, beginning day 2 P.I., with or without hMSC administration (5×10⁵ cells) on day 2 P.I. and sacrificed on day 7 P.I. …”

Transplantation of Exendin-4 pretreated ADSCs decrease apoptosis, fibrosis, and promote angiogenesis. by Jianfeng Liu (122580)

hESCs-CM decreased cancer cells growth. by Shufeng Zhou (398572)

Subjects:

Cooperativity decreases with the expression level of CheA. by Stephan Eismann (835052)

KOR-agonist (U50'488) and MOR-agonist (DAMGO) decrease symptoms in OVA-allergic mice. by Swantje C. Duncker (154707)

EC50 and percentage decrease in intracellular <i>Listeria</i> viability for effective compounds. by Marie-Eve Charbonneau (5658799)

Running increased neural stem cell proliferation in the dentate gyrus, but did not decrease inflammation. by Kaja Falkenhain (9317016)

Over-expression of IL13Rα2 is associated with decreased patient survival. by Christine E. Brown (167785)